Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes
Schüler R, Osterhoff MA, Frahnow T, Möhlig M, Spranger J, Stefanovski D, Bergman RN, Xu L, Seltmann A-C, Kabisch S, Hornemann S, et al. (2017)
Scientific Reports 7(1): 9234.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Schüler, Rita;
Osterhoff, Martin A.;
Frahnow, TuridUniBi ;
Möhlig, Matthias;
Spranger, Joachim;
Stefanovski, Darko;
Bergman, Richard N.;
Xu, Li;
Seltmann, Anne-Cathrin;
Kabisch, Stefan;
Hornemann, Silke;
Kruse, Michael
Alle
Alle
Erscheinungsjahr
2017
Zeitschriftentitel
Scientific Reports
Band
7
Ausgabe
1
Art.-Nr.
9234
Urheberrecht / Lizenzen
ISSN
2045-2322
Page URI
https://pub.uni-bielefeld.de/record/2933482
Zitieren
Schüler R, Osterhoff MA, Frahnow T, et al. Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports. 2017;7(1): 9234.
Schüler, R., Osterhoff, M. A., Frahnow, T., Möhlig, M., Spranger, J., Stefanovski, D., Bergman, R. N., et al. (2017). Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports, 7(1), 9234. doi:10.1038/s41598-017-08300-7
Schüler, Rita, Osterhoff, Martin A., Frahnow, Turid, Möhlig, Matthias, Spranger, Joachim, Stefanovski, Darko, Bergman, Richard N., et al. 2017. “Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes”. Scientific Reports 7 (1): 9234.
Schüler, R., Osterhoff, M. A., Frahnow, T., Möhlig, M., Spranger, J., Stefanovski, D., Bergman, R. N., Xu, L., Seltmann, A. - C., Kabisch, S., et al. (2017). Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports 7:9234.
Schüler, R., et al., 2017. Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports, 7(1): 9234.
R. Schüler, et al., “Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes”, Scientific Reports, vol. 7, 2017, : 9234.
Schüler, R., Osterhoff, M.A., Frahnow, T., Möhlig, M., Spranger, J., Stefanovski, D., Bergman, R.N., Xu, L., Seltmann, A.-C., Kabisch, S., Hornemann, S., Kruse, M., Pfeiffer, A.F.H.: Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports. 7, : 9234 (2017).
Schüler, Rita, Osterhoff, Martin A., Frahnow, Turid, Möhlig, Matthias, Spranger, Joachim, Stefanovski, Darko, Bergman, Richard N., Xu, Li, Seltmann, Anne-Cathrin, Kabisch, Stefan, Hornemann, Silke, Kruse, Michael, and Pfeiffer, Andreas F. H. “Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes”. Scientific Reports 7.1 (2017): 9234.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Link(s) zu Volltext(en)
Access Level
Closed Access
Daten bereitgestellt von European Bioinformatics Institute (EBI)
1 Zitation in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans.
Schüler R, Seebeck N, Osterhoff MA, Witte V, Flöel A, Busjahn A, Jais A, Brüning JC, Frahnow T, Kabisch S, Pivovarova O, Hornemann S, Kruse M, Pfeiffer AFH., Mol Metab 11(), 2018
PMID: 29506909
Schüler R, Seebeck N, Osterhoff MA, Witte V, Flöel A, Busjahn A, Jais A, Brüning JC, Frahnow T, Kabisch S, Pivovarova O, Hornemann S, Kruse M, Pfeiffer AFH., Mol Metab 11(), 2018
PMID: 29506909
27 References
Daten bereitgestellt von Europe PubMed Central.
Modulation of glucose metabolism by the renin-angiotensin-aldosterone system.
Favre GA, Esnault VL, Van Obberghen E., Am. J. Physiol. Endocrinol. Metab. 308(6), 2015
PMID: 25564475
Favre GA, Esnault VL, Van Obberghen E., Am. J. Physiol. Endocrinol. Metab. 308(6), 2015
PMID: 25564475
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group., Arch. Intern. Med. 166(20), 2006
PMID: 17101936
Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group., Arch. Intern. Med. 166(20), 2006
PMID: 17101936
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
Niklason A, Hedner T, Niskanen L, Lanke J; Captopril Prevention Project Study Group., J. Hypertens. 22(3), 2004
PMID: 15076172
Niklason A, Hedner T, Niskanen L, Lanke J; Captopril Prevention Project Study Group., J. Hypertens. 22(3), 2004
PMID: 15076172
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction., Circulation 107(9), 2003
PMID: 12628950
Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction., Circulation 107(9), 2003
PMID: 12628950
Ramipril and the development of diabetes.
Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators., JAMA 286(15), 2001
PMID: 11597291
Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators., JAMA 286(15), 2001
PMID: 11597291
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.
DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators, Gerstein HC, Mohan V, Avezum A, Bergenstal RM, Chiasson JL, Garrido M, MacKinnon I, Rao PV, Zinman B, Jung H, Joldersma L, Bosch J, Yusuf S, Diaz R, Albisu J, Albisu D, Alvarez MS, Alzogoray M, Angelelli N, Ankudowicz V, Avaca H, Bello F, Bergamo S, Botto M, Busatta M, Caccavo A, Caime G, Carrillo N, Carrique A, Carrique P, Cartasegna L, Castellanos C, Centeno M, Chacon C, Cipullo M, Cismondi M, Citta L, Cristofaro PC, Crunger P, Cunero C, De Loredo L, De Loredo S, Del Pino E, Denaro R, Detzel G, Duarte C, Espinosa M, Ferrari G, Gambarte A, Garrido M, Garrido I, Giachello F, Guaymas G, Hoffman V, Insausti E, Laugle C, Lobo Marquez L, Luciardi H, Luduena Clos E, Luna M, Majul M, Maldonado N, Manuale O, Marcucci G, Martinez G, Marzetti E, Molina M, Morell Y, Navarrete S, Nieto F, Nunez M, Orce R, Pastrana M, Pelliza M, Pisaentin J, Piskorz D, Plastino M, Ramos H, Rappi S, Risolo A, Rodriguez H, Rodriguez C, Sago L, Sanchez J, Schygiel P, Sorensen P, Streitenberger P, Tommasi L, Vico M, Vizcaya Castro A, Zaidman C, Shaw J, Zimmet P, Batrouney B, Ching H, Cohen N, Colman P, Davidson M, Gunser A, Lawton M, Lynch L, Nairn J, Nankervis A, Palmer N, Smith G, Stuckey B, Sturdy G, Wagner J, Campbell G, Jones D, Jones M, Stubbs C, Bertolami M, Branco de Araujo D, Faludi A, Nakamura Y, Zatz H, Abbott C, Anand S, Anderlic T, Armstrong M, Auger D, Barnie A, Belanger A, Berard L, Bolduc H, Bonnell J, Brault S, Breen A, Chan Y, Chiasson JL, Dagenais G, Davis A, DeCurtis D, Donat D, Dufour A, Dumas R, Feig D, Gauthier S, Gourgues M, Gupta M, Hanley A, Hannah G, Harris S, Hill K, Houlden R, Hunt D, Hutchinson K, Johnson D, Kajil M, LaValle T, Leroux M, Lochnan H, Marin M, MacLean S, Mallette D, McCarthy G, McCarthy V, Mitchell J, Nyomba G, Ouellet G, Petrella R, Petrella S, Pockett S, Poisson D, Rabasa-Lhoret R, Russell L, Stevenson K, Tsigoulis M, Robert C, Vachon F, Winkler L, Woo V, Zaniol D, Zinman B, Larenas G, Raddatz Kiefer V, Roddriguez L, Toro F, Mohan V, Aravind S, Aravind SR, Ayyar V, Bantwal G, Dhope R, Gayatri R, Gopal U, Idiculla J, Jayanthi S, Kale S, Karkuzhali K, Padmalatha Devi M, Pais P, Poongothai S, Prakash S, Ramu M, Rao PV, Savitha G, Sudha S, Sujatha I, Yajnik C, Cardona E, Pascoe S, Abuomar J, Bergenstal R, Berrios Lopez L, Burgos-Calderon R, Coley L, Cushman W, Fuste P, Guzman Serrano B, Monk A, Pla A, Posada J, Santiago O, Thomas L, Walsh S, Bosch J, Desai D, Gerstein HC, Greenspan L, Haladyn JK, Joldersma L, Jung H, MacRae L, Pogue J, Santarelli L, Yusuf S., Diabetologia 54(3), 2010
PMID: 21116607
DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators, Gerstein HC, Mohan V, Avezum A, Bergenstal RM, Chiasson JL, Garrido M, MacKinnon I, Rao PV, Zinman B, Jung H, Joldersma L, Bosch J, Yusuf S, Diaz R, Albisu J, Albisu D, Alvarez MS, Alzogoray M, Angelelli N, Ankudowicz V, Avaca H, Bello F, Bergamo S, Botto M, Busatta M, Caccavo A, Caime G, Carrillo N, Carrique A, Carrique P, Cartasegna L, Castellanos C, Centeno M, Chacon C, Cipullo M, Cismondi M, Citta L, Cristofaro PC, Crunger P, Cunero C, De Loredo L, De Loredo S, Del Pino E, Denaro R, Detzel G, Duarte C, Espinosa M, Ferrari G, Gambarte A, Garrido M, Garrido I, Giachello F, Guaymas G, Hoffman V, Insausti E, Laugle C, Lobo Marquez L, Luciardi H, Luduena Clos E, Luna M, Majul M, Maldonado N, Manuale O, Marcucci G, Martinez G, Marzetti E, Molina M, Morell Y, Navarrete S, Nieto F, Nunez M, Orce R, Pastrana M, Pelliza M, Pisaentin J, Piskorz D, Plastino M, Ramos H, Rappi S, Risolo A, Rodriguez H, Rodriguez C, Sago L, Sanchez J, Schygiel P, Sorensen P, Streitenberger P, Tommasi L, Vico M, Vizcaya Castro A, Zaidman C, Shaw J, Zimmet P, Batrouney B, Ching H, Cohen N, Colman P, Davidson M, Gunser A, Lawton M, Lynch L, Nairn J, Nankervis A, Palmer N, Smith G, Stuckey B, Sturdy G, Wagner J, Campbell G, Jones D, Jones M, Stubbs C, Bertolami M, Branco de Araujo D, Faludi A, Nakamura Y, Zatz H, Abbott C, Anand S, Anderlic T, Armstrong M, Auger D, Barnie A, Belanger A, Berard L, Bolduc H, Bonnell J, Brault S, Breen A, Chan Y, Chiasson JL, Dagenais G, Davis A, DeCurtis D, Donat D, Dufour A, Dumas R, Feig D, Gauthier S, Gourgues M, Gupta M, Hanley A, Hannah G, Harris S, Hill K, Houlden R, Hunt D, Hutchinson K, Johnson D, Kajil M, LaValle T, Leroux M, Lochnan H, Marin M, MacLean S, Mallette D, McCarthy G, McCarthy V, Mitchell J, Nyomba G, Ouellet G, Petrella R, Petrella S, Pockett S, Poisson D, Rabasa-Lhoret R, Russell L, Stevenson K, Tsigoulis M, Robert C, Vachon F, Winkler L, Woo V, Zaniol D, Zinman B, Larenas G, Raddatz Kiefer V, Roddriguez L, Toro F, Mohan V, Aravind S, Aravind SR, Ayyar V, Bantwal G, Dhope R, Gayatri R, Gopal U, Idiculla J, Jayanthi S, Kale S, Karkuzhali K, Padmalatha Devi M, Pais P, Poongothai S, Prakash S, Ramu M, Rao PV, Savitha G, Sudha S, Sujatha I, Yajnik C, Cardona E, Pascoe S, Abuomar J, Bergenstal R, Berrios Lopez L, Burgos-Calderon R, Coley L, Cushman W, Fuste P, Guzman Serrano B, Monk A, Pla A, Posada J, Santiago O, Thomas L, Walsh S, Bosch J, Desai D, Gerstein HC, Greenspan L, Haladyn JK, Joldersma L, Jung H, MacRae L, Pogue J, Santarelli L, Yusuf S., Diabetologia 54(3), 2010
PMID: 21116607
Effect of ramipril on the incidence of diabetes.
DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR., N. Engl. J. Med. 355(15), 2006
PMID: 16980380
DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR., N. Engl. J. Med. 355(15), 2006
PMID: 16980380
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects.
Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group, Heine RJ, Dekker J, de Rooij S, Nijpels G, Boorsma W, Mitrakou A, Tournis S, Kyriakopoulou K, Thomakos P, Lalic K, Jotic A, Lukic L, Civcic M, Nolan J, Yeow TP, Murphy M, DeLong C, Neary G, Colgan MP, Hatunic M, Konrad T, Bohles H, Fuellert S, Baer F, Zuchhold H, Golay A, Harsch Bobbioni E, Barthassat V, Makoundou V, Lehmann TN, Merminod T, Dundee JR, Perry C, Neary F, MacDougall C, Shields K, Malcolm L, Laakso M, Salmenniemi U, Aura A, Raisanen R, Ruotsalainen U, Sistonen T, Laitinen M, Saloranta H, Coppack SW, McIntosh N, Ross J, Pettersson L, Khadobaksh P, Rennes F, Brac de la Perriere A, Louche-Pelissier C, Maitrepierre C, Peyrat J, Beltran S, Serusclat A, Gabriel R, Sanchez EM, Carraro R, Friera A, Novella B, Nilsson P, Persson M, Ostling G, Melander O, Burri P, Piatti PM, Setola E, Galluccio E, Minicucci F, Colleluori A, Ibrahim IM, Jayapaul M, Carman D, Ryan C, Short K, McGrady Y, Richardson D, Beck-Nielsen H, Staehr P, Hojlund K, Vestergaard V, Olsen C, Hansen L, Bolli GB, Porcellati F, Fanelli C, Lucidi P, Calcinaro F, Saturni A, Ferrannini E, Natali A, Muscelli E, Pinnola S, Kozakova M, Mingrone G, Guidone C, Di Rocco P, Anderwald C, Bischof M, Promintzer M, Krebs M, Mandl M, Hofer A, Luger A, Waldhausl W, Roden M, Dekker JM, Mari A, Gaffney P, Boran G, Kok A, Gastaldelli A, Ciociaro D, Guillanneuf MT, Mhamdi L, Landucci L, Hills S, Mota L, Pacini G, Cavaggion C, Hills SA., Diabetes Care 31(4), 2008
PMID: 18235053
Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group, Heine RJ, Dekker J, de Rooij S, Nijpels G, Boorsma W, Mitrakou A, Tournis S, Kyriakopoulou K, Thomakos P, Lalic K, Jotic A, Lukic L, Civcic M, Nolan J, Yeow TP, Murphy M, DeLong C, Neary G, Colgan MP, Hatunic M, Konrad T, Bohles H, Fuellert S, Baer F, Zuchhold H, Golay A, Harsch Bobbioni E, Barthassat V, Makoundou V, Lehmann TN, Merminod T, Dundee JR, Perry C, Neary F, MacDougall C, Shields K, Malcolm L, Laakso M, Salmenniemi U, Aura A, Raisanen R, Ruotsalainen U, Sistonen T, Laitinen M, Saloranta H, Coppack SW, McIntosh N, Ross J, Pettersson L, Khadobaksh P, Rennes F, Brac de la Perriere A, Louche-Pelissier C, Maitrepierre C, Peyrat J, Beltran S, Serusclat A, Gabriel R, Sanchez EM, Carraro R, Friera A, Novella B, Nilsson P, Persson M, Ostling G, Melander O, Burri P, Piatti PM, Setola E, Galluccio E, Minicucci F, Colleluori A, Ibrahim IM, Jayapaul M, Carman D, Ryan C, Short K, McGrady Y, Richardson D, Beck-Nielsen H, Staehr P, Hojlund K, Vestergaard V, Olsen C, Hansen L, Bolli GB, Porcellati F, Fanelli C, Lucidi P, Calcinaro F, Saturni A, Ferrannini E, Natali A, Muscelli E, Pinnola S, Kozakova M, Mingrone G, Guidone C, Di Rocco P, Anderwald C, Bischof M, Promintzer M, Krebs M, Mandl M, Hofer A, Luger A, Waldhausl W, Roden M, Dekker JM, Mari A, Gaffney P, Boran G, Kok A, Gastaldelli A, Ciociaro D, Guillanneuf MT, Mhamdi L, Landucci L, Hills S, Mota L, Pacini G, Cavaggion C, Hills SA., Diabetes Care 31(4), 2008
PMID: 18235053
ACE, angiotensinogen and obesity: a potential pathway leading to hypertension.
Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T., J Hum Hypertens 11(2), 1997
PMID: 9140797
Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T., J Hum Hypertens 11(2), 1997
PMID: 9140797
Weight loss and the renin-angiotensin-aldosterone system.
Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM., Hypertension 45(3), 2005
PMID: 15630041
Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM., Hypertension 45(3), 2005
PMID: 15630041
Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults.
Harp JB, Henry SA, DiGirolamo M., Obes. Res. 10(10), 2002
PMID: 12376578
Harp JB, Henry SA, DiGirolamo M., Obes. Res. 10(10), 2002
PMID: 12376578
Circulating ACE is a predictor of weight loss maintenance not only in overweight and obese women, but also in men.
Wang P, Holst C, Wodzig WK, Andersen MR, Astrup A, van Baak MA, Larsen TM, Jebb SA, Kafatos A, Pfeiffer AF, Martinez JA, Handjieva-Darlenska T, Kunesova M, Viguerie N, Langin D, Saris WH, Mariman EC; Diogenes consortium., Int J Obes (Lond) 36(12), 2012
PMID: 22270380
Wang P, Holst C, Wodzig WK, Andersen MR, Astrup A, van Baak MA, Larsen TM, Jebb SA, Kafatos A, Pfeiffer AF, Martinez JA, Handjieva-Darlenska T, Kunesova M, Viguerie N, Langin D, Saris WH, Mariman EC; Diogenes consortium., Int J Obes (Lond) 36(12), 2012
PMID: 22270380
AUTHOR UNKNOWN, 0
Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women's Heart and Health Study (BWHHS).
Abdollahi MR, Huang S, Rodriguez S, Guthrie PA, Smith GD, Ebrahim S, Lawlor DA, Day IN, Gaunt TR., Dis. Markers 24(1), 2008
PMID: 18057531
Abdollahi MR, Huang S, Rodriguez S, Guthrie PA, Smith GD, Ebrahim S, Lawlor DA, Day IN, Gaunt TR., Dis. Markers 24(1), 2008
PMID: 18057531
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N., N. Engl. J. Med. 336(16), 1997
PMID: 9099655
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N., N. Engl. J. Med. 336(16), 1997
PMID: 9099655
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.
Katzov H, Bennet AM, Kehoe P, Wiman B, Gatz M, Blennow K, Lenhard B, Pedersen NL, de Faire U, Prince JA., Hum. Mol. Genet. 13(21), 2004
PMID: 15367486
Katzov H, Bennet AM, Kehoe P, Wiman B, Gatz M, Blennow K, Lenhard B, Pedersen NL, de Faire U, Prince JA., Hum. Mol. Genet. 13(21), 2004
PMID: 15367486
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F., J. Clin. Invest. 86(4), 1990
PMID: 1976655
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F., J. Clin. Invest. 86(4), 1990
PMID: 1976655
Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM.
Huang XH, Rantalaiho V, Wirta O, Pasternack A, Koivula T, Hiltunen T, Nikkari T, Lehtimaki T., Hum. Genet. 102(3), 1998
PMID: 9544854
Huang XH, Rantalaiho V, Wirta O, Pasternack A, Koivula T, Hiltunen T, Nikkari T, Lehtimaki T., Hum. Genet. 102(3), 1998
PMID: 9544854
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension.
Jeng JR, Shieh SM, Harn HJ, Lee MM, Sheu WH, Jeng CY., J. Hypertens. 15(9), 1997
PMID: 9321743
Jeng JR, Shieh SM, Harn HJ, Lee MM, Sheu WH, Jeng CY., J. Hypertens. 15(9), 1997
PMID: 9321743
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
Nagi DK, Mansfield MW, Stickland MH, Grant PJ., Diabet. Med. 12(11), 1995
PMID: 8582133
Nagi DK, Mansfield MW, Stickland MH, Grant PJ., Diabet. Med. 12(11), 1995
PMID: 8582133
The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects.
Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, Humphries SE., Mol. Genet. Metab. 84(1), 2005
PMID: 15639198
Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, Humphries SE., Mol. Genet. Metab. 84(1), 2005
PMID: 15639198
Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population.
Gutierrez C, Vendrell J, Pastor R, Llor C, Aguilar C, Broch M, Richart C., Metab. Clin. Exp. 46(8), 1997
PMID: 9258285
Gutierrez C, Vendrell J, Pastor R, Llor C, Aguilar C, Broch M, Richart C., Metab. Clin. Exp. 46(8), 1997
PMID: 9258285
Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis.
Niu W, Qi Y, Gao P, Zhu D., Endocr. J. 57(5), 2010
PMID: 20160398
Niu W, Qi Y, Gao P, Zhu D., Endocr. J. 57(5), 2010
PMID: 20160398
Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis.
Zhou JB, Yang JK, Lu JK, An YH., Mol. Biol. Rep. 37(1), 2009
PMID: 19655271
Zhou JB, Yang JK, Lu JK, An YH., Mol. Biol. Rep. 37(1), 2009
PMID: 19655271
Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors.
Smedman AE, Gustafsson IB, Berglund LG, Vessby BO., Am. J. Clin. Nutr. 69(1), 1999
PMID: 9925119
Smedman AE, Gustafsson IB, Berglund LG, Vessby BO., Am. J. Clin. Nutr. 69(1), 1999
PMID: 9925119
MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.
Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN., Diabetes Technol. Ther. 5(6), 2003
PMID: 14709204
Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN., Diabetes Technol. Ther. 5(6), 2003
PMID: 14709204
The prevention or delay of type 2 diabetes.
American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases., Diabetes Care 25(4), 2002
PMID: 11919135
American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases., Diabetes Care 25(4), 2002
PMID: 11919135
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 28835639
PubMed | Europe PMC
Suchen in